EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

Liver Cancer SUMMIT 2020

 

6-8 February 2020 Prague
Close
N. Poster
Poster title
Applicant name
Status
  P04-01 Application of BCLC-B subclassification and the Hong Kong Liver Cancer Systems to Intermediate Stage Hepatocellular Carcinoma Coskun Ozer Demirtas Received Received
  P05-01 Hepatocellular Carcinoma in Non-Cirrhotic Liver Arises in a More Advanced Tumoral Appearance Coskun Ozer Demirtas Received Received
  P04-02 Curative versus palliative treatments for recurrent hepatocellular carcinoma: an italian nationwide study Francesca Carissimi Received Received
  P03-02 PIVKA-II is a useful biomarker for hepatocellular carcinoma in caucasian HCV cirrhotic patients treated with direct-acting antivirals Elisabetta Degasperi Received Received
  P03-03 External Validation of the Toronto Hepatocellular Carcinoma Risk Index in Turkish Cirrhotic Patients Coskun Ozer Demirtas Received Received
  P07-04 Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinomas nathalie guedj Received Received
  P02-05 Immunological approach to identify predictive factors for development of hepatocellular carcinoma in patients treated with direct-acting antivirals Zuzana MACEK JILKOVA Received Received
  P03-06 The impact of postoperative ascites on survival after hepatectomy for hepatocellular carcinoma: A multicentric nation-based analysis Simone Famularo Received Received
  P07-07 Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy. David Pinato Received Received
  P03-08 Optimisation and qualification of tumour mutational burden (TMB) by targeted next-generation sequencing (tNGS) as a clinically applicable biomarker in hepatocellular carcinoma (HCC). David Pinato Received Received
  P02-13 A genetic risk score predicts de novo hepatocellular carcinoma in hepatitis C cirrhotic patients treated with direct-acting antivirals Elisabetta Degasperi Received Received
  P01-14 Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma David Pinato Received Received
  P04-15 Circulating levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of biliary tract cancer Sven Loosen Received Received
  P06-20 Involvement of the glycan-binding protein galectin-1 in hepatocellular carcinoma cell drug resistance María Fernanda Troncoso Received Received
  P04-21 Inhibitory effects of butyrate carrier structured lipids on persistent preneoplastic lesions induced by the resistant hepatocyte model of hepatocarcinogenesis Juliana Marques Affonso Received Received
  P99-99 Prueba Daniel Zaldumbide Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:30 Fri 8:30-15:00
00:02
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

Liver Cancer SUMMIT 2020

 

6-8 February 2020 Prague
HELP LINE
Manage Orders
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 06/02/2020 TO 06/02/2021
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                  
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 04/02/2020
Upload Poster
Upload Oral Presentation of Video
Upload
Poster
Upload Oral
Presentation or Video




PosterSessionOnline
Logo Draft
 
Logo Cert